United States of America
Jim Traa is a recognized healthcare industry veteran with over 28 years of healthcare industry and management experience in top-level executive and leadership positions. Currently, Jim is a Managing Partner of the Targeted Technology Funds and acting Chief Business Officer for two of Fund I’s portfolio companies; ViroXis Corporation and Santalis Pharmaceuticals. Prior to assuming his current responsibilities, Jim was a Vice President for Caris Life Sciences, a leading biosciences company focused on developing and delivering innovative molecular profiling services. Prior to Caris Life Sciences, Jim held numerous senior leadership positions within Sanofi Genzyme’s Biosurgical Specialties business unit specializing in the development and introduction of novel biotherapeutic and biomaterial products. Jim served for 9 years as a Commissioned Officer in the United States Navy where he held several leadership positions within the Surface Warfare and Aviation communities.